A Study to Assess Adverse Events and Change in Disease Activity of Intravenously (IV) Infused ABBV-324 in Adult Participants With Hepatocellular Cancer (HCC) or Squamous-Cell Non-Small Cell Lung Cancer (LUSC)

RECRUITING

SCRI Oncology Partners /ID# 272750, Nashville

RECRUITING

University of Chicago Medical Center /ID# 270517, Chicago

RECRUITING

Washington University /ID# 275757, St Louis

RECRUITING

USC Norris Comprehensive Cancer Center /ID# 271573, Los Angeles

RECRUITING

UCLA - Santa Monica /ID# 275995, Santa Monica

RECRUITING

City of Hope National Medical Center /ID# 270526, Duarte

RECRUITING

Hadassah Medical Center-Hebrew University /ID# 271235, Jerusalem

RECRUITING

City of Hope - Orange County Lennar Foundation Cancer Center /ID# 276120, Irvine

RECRUITING

Rambam Health Care Campus /ID# 270604, Haifa

RECRUITING

Rabin Medical Center /ID# 271236, Petah Tikva

RECRUITING

UC Irvine Medical Center /ID# 270507, Orange

RECRUITING

National Cancer Center Hospital East /ID# 270585, Kashiwa-shi

RECRUITING

Kansai Medical University Hospital /ID# 272884, Hirakata-shi

RECRUITING

National Cancer Center Hospital /ID# 270583, Chuo-Ku

RECRUITING

Fdi Clinical Research /ID# 272960, San Juan